By
Latest Stories
Don’t miss our hot and upcoming stories
AI Meets Neuroscience: BullFrog AI and LIBD Unlock New Frontiers in Psychiatric Disorder Research
Gaithersburg, Md – Jan 17 2024 BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW), a technology-enabled…
Nvidia Expands AI Drug Discovery with Amgen and Recursion Collaborations
JPM Conference, January 8, 2024 Nvidia is advancing its footprint in AI-powered drug discovery through…
Insilico Medicine Achieves Milestone with Positive Phase I Results for AI-Designed IBD Drug ISM5411
CAMBRIDGE, Massachusetts, January 7, 2024 Insilico Medicine, a clinical-stage leader in generative AI-driven drug discovery…
Bristol Myers Squibb Taps AI-Driven Discovery with Terray Therapeutics to Accelerate Small Molecule Drug Development
Los Angeles – Dec 14, 2023 Terray Therapeutics, a leader in AI-driven small molecule discovery,…